These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 20387065

  • 1. Impressive response to temsirolimus in a patient with chemotherapy refractory diffuse large B-cell non-Hodgkin's lymphoma.
    Kiewe P, Thiel E.
    Ann Hematol; 2011 Jan; 90(1):109-10. PubMed ID: 20387065
    [No Abstract] [Full Text] [Related]

  • 2. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
    Huang HQ, Bu Q, Xia ZJ, Lin XB, Wang FH, Li YH, Peng YL, Pan ZH, Wang SS, Lin TY, Jiang WQ, Guan ZZ.
    Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
    [Abstract] [Full Text] [Related]

  • 3. Intravascular large B-cell lymphoma: remission after rituximab-cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy.
    Horváth B, Demeter J, Eros N, Hársing J, Csomor J, Matolcsy A, Bottlik G, Gyori G, Marschalkó M, Kárpáti S.
    J Am Acad Dermatol; 2009 Nov; 61(5):885-8. PubMed ID: 19632742
    [Abstract] [Full Text] [Related]

  • 4. [A three-year experience with use of mabthera (rituximab) in treatment of indolent non-Hodgkin's disease refractory to standard chemotherapy].
    Korolenko VO, Gershanovich ML, Tikhonova VV.
    Vopr Onkol; 2004 Nov; 50(4):421-5. PubMed ID: 15605764
    [No Abstract] [Full Text] [Related]

  • 5. [Preliminary outcome for patients with relapsed or resistant advanced non-Hodgkin's lymphoma treated by EPOCH regimen].
    Huang HQ, Jiang WQ, Wang W, Zhou ZM, Xia ZJ, Lin XB, Li YH, Xu RH, Zhang L, Xu GC, Sun XF, Liu DG, He YJ, Guan ZZ.
    Ai Zheng; 2003 Apr; 22(4):389-92. PubMed ID: 12703995
    [Abstract] [Full Text] [Related]

  • 6. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR, Zhang YJ, Xie FY, Zheng W, Li HX, Xia YF, Lin TY, Lu TX.
    Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
    [Abstract] [Full Text] [Related]

  • 7. [Clinical features of 89 patients with primary non-Hodgkin's lymphoma of the tonsil].
    Qin Y, Shi YK, He XH, Yang JL, Yang S, Yu YX, Li B, Wang QL, Zhou LQ, Sun Y.
    Ai Zheng; 2006 Apr; 25(4):481-5. PubMed ID: 16613685
    [Abstract] [Full Text] [Related]

  • 8. Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma.
    Gordon LI, Harrington D, Andersen J, Colgan J, Glick J, Neiman R, Mann R, Resnick GD, Barcos M, Gottlieb A.
    N Engl J Med; 1992 Nov 05; 327(19):1342-9. PubMed ID: 1383819
    [Abstract] [Full Text] [Related]

  • 9. [Prognostic factors of invasive non-Hodgkin's lymphoma].
    Yu H, Hong XN, Li J, Peng LP, Ye L.
    Zhonghua Zhong Liu Za Zhi; 2007 Jun 05; 29(6):461-3. PubMed ID: 17974284
    [Abstract] [Full Text] [Related]

  • 10. Clinical investigations in aggressive non-Hodgkin lymphoma.
    Jonathan F.
    Clin Adv Hematol Oncol; 2008 Sep 05; 6(9):7-8. PubMed ID: 18998259
    [No Abstract] [Full Text] [Related]

  • 11. [NEO-MACOP-B chemotherapy for the treatment of advanced-stage aggressive non-Hodgkin's lymphoma].
    Kohda K, Tsuji A, Takayanagi N, Takeda M, Hayashi S, Takimoto R, Fujisaki Y, Tsuji Y, Ezoe A, Nakazawa O.
    Gan To Kagaku Ryoho; 1993 Nov 05; 20(14):2183-9. PubMed ID: 7694548
    [Abstract] [Full Text] [Related]

  • 12. Immunochemotherapy for Bcl-2 and MUM-negative aggressive primary cutaneous B-cell non-Hodgkin's lymphoma.
    Colovic N, Jurisic V, Terzic T, Atkinson HD, Colovic M.
    Arch Dermatol Res; 2009 Oct 05; 301(9):689-92. PubMed ID: 19495780
    [Abstract] [Full Text] [Related]

  • 13. [Prognosis of primary non-Hodgkin's lymphoma of the breast].
    Guo HY, Zhao XM, Cao JN, Hu XC, Yin JL, Hong XN, Li J.
    Zhonghua Zhong Liu Za Zhi; 2008 Mar 05; 30(3):200-2. PubMed ID: 18756936
    [Abstract] [Full Text] [Related]

  • 14. Primary large B-cell lymphoma of the bone marrow.
    Hishizawa M, Okamoto K, Chonabayashi K, Kaneko H, Watanabe M, Tsudo M.
    Br J Haematol; 2007 Feb 05; 136(3):351. PubMed ID: 17233843
    [No Abstract] [Full Text] [Related]

  • 15. [Treatment of primary mediastinal large B-cell lymphomas].
    Schneider T, Tóth E, Molnár Z, Várady E, Deák B, Horváth A, Horváth GI, Eid H, Schneider K, Lovey J, Keresztes S, Esik O, Lengyel Z, Rosta A.
    Orv Hetil; 2004 Dec 12; 145(50):2531-7. PubMed ID: 15662753
    [Abstract] [Full Text] [Related]

  • 16. [Concurrent chemo-radiotherapy for localized refractory non-Hodgkin's lymphoma--report of two cases].
    Sugimoto T, Matano S, Nishijima H, Kakuta K, Inamura K, Okamura T, Munemoto S, Satoh S.
    Gan To Kagaku Ryoho; 2007 Jan 12; 34(1):125-8. PubMed ID: 17220687
    [Abstract] [Full Text] [Related]

  • 17. Non-Hodgkin's lymphoma (diffuse large B cell lymphoma).
    Copson E.
    Clin Evid; 2006 Jun 12; (15):30-44. PubMed ID: 16973004
    [No Abstract] [Full Text] [Related]

  • 18. A prospective, non-randomised phase 1-2 trial of VACOP-B with filgrastim support for HIV-related non-Hodgkin's lymphoma.
    Sawka CA, Shepherd FA, Franssen E, Brandwein J, Dotten DA, Routy JP, Walker IR, St-Louis J, Taylor M, Arts K, Crump M, Foote M.
    Biotechnol Annu Rev; 2005 Jun 12; 11():381-9. PubMed ID: 16216784
    [Abstract] [Full Text] [Related]

  • 19. Reversible posterior leukoencephalopathy syndrome following R-CHOP therapy for diffuse large B-cell lymphoma.
    Hosoi M, Yamamoto G, Imai Y, Kurokawa M.
    Ann Hematol; 2010 Feb 12; 89(2):207-8. PubMed ID: 19582454
    [No Abstract] [Full Text] [Related]

  • 20. Rituximab and its role as maintenance therapy in non-Hodgkin lymphoma.
    Collins-Burow B, Santos ES.
    Expert Rev Anticancer Ther; 2007 Mar 12; 7(3):257-73. PubMed ID: 17338647
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.